Three more biotechs hit Nas­daq as the sec­tor, now with more than $13B raised, con­tin­ues bar­rel­ing to­ward record

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

Af­ter a sum­mer slum­ber, the biotech IPO mar­ket …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER